Shopping Cart
- Remove All
- Your shopping cart is currently empty
iRGD Peptide 1 TFA is a prototypic tumor-homing peptide with tissue-penetrating capabilities, facilitating deep delivery of therapeutic agents into extravascular tumor tissue. Additionally, it possesses anti-metastatic activity [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | iRGD Peptide 1 TFA is a prototypic tumor-homing peptide with tissue-penetrating capabilities, facilitating deep delivery of therapeutic agents into extravascular tumor tissue. Additionally, it possesses anti-metastatic activity [1]. |
In vitro | The iRGD peptide 1 (iRGD) attenuates tumor cell migration and elicits chemorepulsion in vitro, contingent upon CendR and NRP-1 pathways. This peptide precipitates marked retraction of cell extensions and partial cell detachment, contributing to its repellent effect. Such responses are notably accentuated upon fibronectin exposure, implying CendR's instrumental role in modulating integrin activity [1]. |
In vivo | The iRGD peptide 1 (CRGDKGPDC; 4 μmol/kg; intravenous; qod; 21 days) effectively suppresses spontaneous metastasis in mice [1]. |
Molecular Weight | 1064.08 |
Formula | C37H60F3N13O16S2 |
Storage | keep away from moisture | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.